Welch & Forbes LLC Viatris Inc Transaction History

Welch & Forbes LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 22, 2022	SELL	$9.95 - $12.27 $1,631 - $2,012	-164 Reduced 1.5%	10,802 $113,000
Q1 2022 Apr 25, 2022	SELL	$9.81 - $15.4 $73,015 - $114,622	-7,443 Reduced 40.43%	10,966 $120,000
Q4 2021 Jan 19, 2022	SELL	$12.09 - $14.68 $25,062 - $30,431	-2,073 Reduced 10.12%	18,409 $249,000
Q3 2021 Oct 13, 2021	SELL	$13.25 - $15.13 $61,718 - $70,475	-4,658 Reduced 18.53%	20,482 $277,000
Q2 2021 Jul 22, 2021	SELL	$12.97 - $16.15 $59,117 - $73,611	-4,558 Reduced 15.35%	25,140 $359,000
Q1 2021 Apr 14, 2021	SELL	$13.59 - $18.54 $383,795 - $523,588	-28,241 Reduced 48.74%	29,698 $415,000
Q4 2020 Jan 20, 2021	BUY	$14.3 - $18.74 $828,527 - $1.09 Million	57,939 New	57,939 $1.09 Million

1,102

934M

2.71M

2.4M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $15.8B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Welch & Forbes LLC, based on Form 13F filings with the SEC.

Stay updated on Welch & Forbes LLC with notifications on news.